Holen Sie sich die Stockscreener-App
1.29
0.00%
0.00
Schlusskurs vom Vortag:
$1.29
Offen:
$1.31
24-Stunden-Volumen:
261.86K
Relative Volume:
0.35
Marktkapitalisierung:
$95.32M
Einnahmen:
$311.14M
Nettoeinkommen (Verlust:
$-177.97M
KGV:
-0.5093
EPS:
-2.5329
Netto-Cashflow:
$-20.82M
1W Leistung:
+8.40%
1M Leistung:
-1.53%
6M Leistung:
-45.34%
1J Leistung:
-64.71%
1-Tages-Spanne:
$1.24
$1.33
1-Wochen-Bereich:
$1.20
$1.33
52-Wochen-Spanne:
$0.9551
$4.2908
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.29 | 95.32M | 311.14M | -177.97M | -20.82M | -2.5329 |
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Health Catalyst Inc (HCAT) Share Price Today | Health Catalyst (HCAT) Live NSE/BSE - Value Research
Health Catalyst Q1 2026 Results: Revenue Decline, Client Migration Issues, and Strategic ShiftsNews and Statistics - IndexBox
EDGAR Filing Documents for 0001636422-25-000010 - SEC.gov
MongoDB, Health Catalyst, and Qualys Shares Are Soaring, What You Need To Know - Yahoo Finance
5 Insightful Analyst Questions From Health Catalyst’s Q1 Earnings Call - Yahoo Finance
Health Catalyst (HCAT) seeks declassification vote; board, auditor and pay proposals - Stock Titan
Health Catalyst stock (US42226A1079): Shares jump after recent trading update - AD HOC NEWS
3 Stocks With Recent Gains But Weak Fundamentals, According to May 2026 Analysis - IndexBox
5 insightful analyst questions from Health Catalyst’s Q1 earnings call - MSN
Health Catalyst outlines $260M-$265M 2026 revenue outlook backed by Project Nexus $30M run-rate savings - MSN
Health Catalyst stock (US42226A1079): Earnings update keeps focus on path to profitability - AD HOC NEWS
Health Catalyst Inc stock (US42226A1079): earnings update keeps focus on AI-driven healthcare analyt - AD HOC NEWS
Health Catalyst (HCAT) Stock Trades Up, Here Is Why - Yahoo Finance
Number of shareholders of Health Catalyst, Inc. – DUS:2YP - TradingView
Health Catalyst (NASDAQ: HCAT) group reports 8.3% stake in amended 13G/A - Stock Titan
Health Catalyst (HCAT) Q1 2026 Earnings Transcript - AOL.com
Health Catalyst stock (US42226A1079): Q1 beat with EPS of $0.02, revenue $70.76M - AD HOC NEWS
Healthcare Analytics Market is projected to Hit USD 47.97 - openPR.com
Health Catalyst Q1 2026 Earnings Preview - MSN
Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Liquidia Technologies (LQDA) and Bicara Therapeutics Inc. (BCAX) - The Globe and Mail
Health Catalyst (HCAT) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
HCAT SEC FilingsHealth Catalyst 10-K, 10-Q, 8-K Forms - Stock Titan
Health Catalyst(HCAT) Stock Options Chain | Quotes & News - Moomoo
Health Catalyst Is Maintained at Equal-Weight by Stephens & Co. - Moomoo
Health Catalyst Price Target Cut to $1.75/Share From $2.00 by Stephens & Co. - Moomoo
HCAT Maintained by Stephens & Co. -- Price Target Lowered to $1. - GuruFocus
Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2026 Earnings Call Transcript - Insider Monkey
Health Catalyst Inc (HCAT) Q1 2026 Earnings Call Highlights: Sur - GuruFocus
Health Catalyst Sees 2026 Rev $260M-$265M >HCAT - Moomoo
Health Catalyst (HCAT) Q1 earnings and revenues surpass estimates - MSN
Health Catalyst Q1 Earnings Call Highlights - inkl
Health Catalyst (HCAT) Reports Strong Q1 Revenue and Strategic T - GuruFocus
HCAT Forecasts FY26 Adjusted EBITDA Between $30 Million and $33 - GuruFocus
Earnings call transcript: Health Catalyst Q1 2026 revenue beats forecast - Investing.com UK
HCAT Financials: Income Statement, Balance Sheet & Cash Flow | Health Catalyst - Stock Titan
Earnings call transcript: Health Catalyst Q1 2026 revenue beats forecast By Investing.com - Investing.com Nigeria
Health Catalyst earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Health Catalyst (HCAT) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Compared to Estimates, Health Catalyst (HCAT) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Health Catalyst, Inc. 1Q 2026: Revenue $70.76M, EPS ($1.53) — 10-Q Summary - TradingView
Health Catalyst (NASDAQ:HCAT) Q1 2026 Revenue Beat, Strategic Reset Fuel 11% Stock Surge - ChartMill
Health Catalyst Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Goodwill write-down drives wider Q1 2026 loss at Health Catalyst (HCAT) - Stock Titan
Q1 2026 Health Catalyst Inc Earnings Call Transcript - GuruFocus
HEALTH CATALYST ($HCAT) Releases Q1 2026 Earnings - Quiver Quantitative
Health Catalyst: Q1 Earnings Snapshot - marketscreener.com
Health Catalyst beats Q1 adjusted EBITDA expectations; net loss widens on impairment charge - TradingView
Health Catalyst Reports First Quarter 2026 Results - The Manila Times
Health Catalyst’s (NASDAQ:HCAT) Q1 CY2026 Sales Beat Estimates, Stock Jumps 11.1% - Yahoo Finance
Goodwill hit reshapes Health Catalyst (Nasdaq: HCAT) Q1 2026 results - Stock Titan
Health Catalyst, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
4.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):